143 related articles for article (PubMed ID: 34773664)
1. The pathophysiology of Wilson's disease visualized: A human
Sandahl TD; Gormsen LC; Kjærgaard K; Vendelbo MH; Munk DE; Munk OL; Bender D; Keiding S; Vase KH; Frisch K; Vilstrup H; Ott P
Hepatology; 2022 Jun; 75(6):1461-1470. PubMed ID: 34773664
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Feb; 14(1):70-8. PubMed ID: 21327972
[TBL] [Abstract][Full Text] [Related]
3. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent changes of cerebral copper metabolism in Atp7b
Xie F; Xi Y; Pascual JM; Muzik O; Peng F
Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
[TBL] [Abstract][Full Text] [Related]
5. High value of
Murillo O; Collantes M; Gazquez C; Moreno D; Hernandez-Alcoceba R; Barberia M; Ecay M; Tamarit B; Douar A; Ferrer V; Combal JP; Peñuelas I; Bénichou B; Gonzalez-Aseguinolaza G
Mol Ther Methods Clin Dev; 2022 Sep; 26():98-106. PubMed ID: 35795774
[TBL] [Abstract][Full Text] [Related]
6. Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?
Johnson S
Med Hypotheses; 2001 Feb; 56(2):171-3. PubMed ID: 11425282
[TBL] [Abstract][Full Text] [Related]
7. Distribution of non-ceruloplasmin-bound copper after i.v.
Munk DE; Vendelbo MH; Kirk FT; Rewitz KS; Bender DA; Vase KH; Munk OL; Vilstrup H; Ott P; Sandahl TD
JHEP Rep; 2023 Nov; 5(11):100916. PubMed ID: 37886434
[TBL] [Abstract][Full Text] [Related]
8. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease.
Liggi M; Mais C; Demurtas M; Sorbello O; Demelia E; Civolani A; Demelia L
Scand J Gastroenterol; 2013 Dec; 48(12):1452-8. PubMed ID: 24164422
[TBL] [Abstract][Full Text] [Related]
9. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
10. High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson's disease.
Kucinskas L; Jeroch J; Vitkauskiene A; Sakalauskas R; Petrenkiene V; Kucinskas V; Naginiene R; Schmidt H; Kupcinskas L
World J Gastroenterol; 2008 Oct; 14(38):5876-9. PubMed ID: 18855987
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for diagnosis of Wilson's disease.
Ryan A; Nevitt SJ; Tuohy O; Cook P
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Assessment of Copper(II) in Wilson's Disease Based on Photoacoustic Imaging and Ratiometric Surface-Enhanced Raman Scattering.
Feng H; Fu Q; Du W; Zhu R; Ge X; Wang C; Li Q; Su L; Yang H; Song J
ACS Nano; 2021 Feb; 15(2):3402-3414. PubMed ID: 33508938
[TBL] [Abstract][Full Text] [Related]
13. Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load.
Gray LW; Peng F; Molloy SA; Pendyala VS; Muchenditsi A; Muzik O; Lee J; Kaplan JH; Lutsenko S
PLoS One; 2012; 7(6):e38327. PubMed ID: 22802922
[TBL] [Abstract][Full Text] [Related]
14. Wilson's disease: monocentric experiences over a period of 10 years [corrected].
Prochazkova D; Pouchla S; Mejzlik V; Konecna P; Michalek J; Bartosova D; Hrstkova H
Klin Padiatr; 2009 Dec; 221(7):419-24. PubMed ID: 20013564
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study.
Munk DE; Lund Laursen T; Teicher Kirk F; Vilstrup H; Ala A; Gormsen LC; Ott P; Damgaard Sandahl T
Sci Rep; 2022 Aug; 12(1):14714. PubMed ID: 36038585
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders.
Emilie Munk D; Teicher Kirk F; Vendelbo M; Vase K; Munk O; Ott P; Damgaard Sandahl T
J Vis Exp; 2023 Apr; (194):. PubMed ID: 37184248
[TBL] [Abstract][Full Text] [Related]
17. Constructing "smart" chelators by using an activatable prochelator strategy for the treatment of Wilson's disease.
Wang C; Wang R; Zhao L; Wang S; Liu Y; Zhao J; Dong Y; Liu L; Wei P; Wu ZY; Yi T
Redox Biol; 2024 Apr; 70():103076. PubMed ID: 38340635
[TBL] [Abstract][Full Text] [Related]
18. Effects of tetrathiomolybdate on copper metabolism in healthy volunteers and in patients with Wilson disease.
Kirk FT; Munk DE; Swenson ES; Quicquaro AM; Vendelbo MH; Larsen A; Schilsky ML; Ott P; Sandahl TD
J Hepatol; 2024 Apr; 80(4):586-595. PubMed ID: 38081365
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
[TBL] [Abstract][Full Text] [Related]
20. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease.
Lyon TD; Fell GS; Gaffney D; McGaw BA; Russell RI; Park RH; Beattie AD; Curry G; Crofton RJ; Gunn I
Clin Sci (Lond); 1995 Jun; 88(6):727-32. PubMed ID: 7634759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
